Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Balchem (BCPC) Research & Development (2016 - 2026)

Balchem (BCPC) has disclosed Research & Development for 17 consecutive years, with $5.9 million as the latest value for Q1 2026.

  • For Q1 2026, Research & Development rose 26.15% year-over-year to $5.9 million; the TTM value through Mar 2026 reached $19.7 million, up 13.68%, while the annual FY2025 figure was $18.5 million, 10.22% up from the prior year.
  • Research & Development hit $5.9 million in Q1 2026 for Balchem, up from $5.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $5.9 million in Q1 2026 and bottomed at $2.9 million in Q2 2022.
  • Average Research & Development over 5 years is $4.0 million, with a median of $3.9 million recorded in 2023.
  • Year-over-year, Research & Development tumbled 35.55% in 2022 and then rose 29.88% in 2023.
  • Balchem's Research & Development stood at $3.0 million in 2022, then grew by 29.39% to $3.9 million in 2023, then rose by 14.58% to $4.5 million in 2024, then increased by 12.02% to $5.1 million in 2025, then grew by 16.41% to $5.9 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $5.9 million, $5.1 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.